Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue

Journal of Pathology

Volumn 189, Issue 4, 1999, Pages 487-495

  Nielsen, Hans Jørgen ^a   Hansen, Ulla ^a   Christensen, Ib Jarle ^b   Reimert, Claus Michael ^c   Brünner, Nils ^b   Moesgaard, Flemming ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b FINSEN LABORATORY   (Denmark)

^c DANISH BILHARZIASIS LABORATORY   (Denmark)

Author keywords

Colorectal cancer; Eosinophils; Lymphocytes; Mast cells; Neutrophils; Peritumoural inflammatory response; Plasma cells; Prognosis; Tumour infiltrating leukocytes

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL INFILTRATION; COLORECTAL CANCER; CONTROLLED STUDY; EOSINOPHIL; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MAST CELL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COLORECTAL NEOPLASMS; DOUBLE-BLIND METHOD; EOSINOPHILS; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MICROSCOPY, VIDEO; MIDDLE AGED; NEOPLASM STAGING; PLASMA CELLS; PROGNOSIS;

EID: 0032716777     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199912)189:4<487::AID-PATH484>3.0.CO;2-I     Document Type: Article

References (48)

1. Monson JR, Ramsden C, Guillou PJ. Decreased interleukin-2 production in patients with gastrointestinal cancer. Br J Surg 1986; 73: 483-486.
2. Nielsen HJ, Moesgaard F, Hammer JH. Effect of ranitidine on low-dose interleukin-2 induced NK-cell activity in patients with liver metastases from colorectal cancer. Eur J Surg Oncol 1995; 21: 526-530.
3. King J, Caplehorn JRM, Ross WB, Morris DL. High serum carcinoembryonic concentration in patients with colorectal liver metastases is associated with poor cell-mediated immunity, which is predictive for survival. Br J Surg 1997; 84: 1382-1385.
4. Nielsen HJ, Hammer JH, Grenvall S, et al. The effect of ranitidine on immune function, tumour response and survival in patients with liver metastases from colorectal cancer. GI Cancer 1996; 1: 183-190.
5. Roth JA. Tumour induced immunosuppression. Surg Gynecol Obstet 1983; 156: 233-240.
6. Ebert EC, Roberts AI, O'Connell M, Robertson FM, Nagase H. Characterization of an immunosuppressive factor derived from colon cancer cells. J Immunol 1987; 138: 2161-2168.
7. Foulds S, Wakefield CH, Giles M, Gillespie J, Dye JF, Guillou PJ. Expression of a suppressive p15E-related epitope in colorectal and gastric cancer. Br J Cancer 1993; 8: 610-616.
8. Bodmer W. T-cell responses to cancer - a new look. Hum Immunol 1991; 30: 259-261.
9. Svennevig JL, Lunde OC, Holter J, Bjørksvig D. Lymphoid infiltration and prognosis in colorectal carcinoma. Br J Cancer 1984; 49: 375-377.
10. Jass JR. Lymphocytic infiltration and survival in rectal cancer. J Clin Pathol 1986; 39: 585-589.
11. Norheim Andersen S, Rognum TO, Lund E, Meling GI, Hauge S. Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis. Br J Cancer 1993; 68: 80-85.
12. Ishii N, Chiba M, lizuka M, Horie Y, Masamune O. Induction of HLA-DR antigen expression on human colonic epithelium by tumour necrosis factor-alpha and interferon-gamma. Scand J Gastroenterol 1994; 29: 903-907.
13. Pullyblank AM, Monson JRT. Monoclonal antibody treatment of colorectal cancer. Br J Surg 1997; 84: 1511-1517.
14. Dalgleish AG. Cancer vaccines. Eur J Cancer 1994; 30A: 1029-1035.
15. Sikora K. Genes, dreams, and cancer. Br Med J 1994; 308; 1217-1221.
16. Sandig V, Brand K, Herwig S, Lukas J, Bartek J, Strauss M. Adenovirally transferred p16 and p53 genes cooperate to induce apoptotic tumour cell death. Nature Med 1997; 3: 313-319.
17. Balch CM, Riley LB, Bae YJ, et al. Patterns of human tumour-infiltrating lymphocytes in 120 human cancers. Arch Surg 1990; 125: 200-205.
18. Nielsen HJ. The effect of histamine type-2 receptor antagonists on posttraumatic immune competence. Dan Med Bull 1995; 42: 162-174.
19. Pretlow TP, Keith EF, Cryar AK, et al. Eosinophil infiltration of human colonic carcinomas as a prognostic indicator. Cancer Res 1983; 43: 2997-3000.
20. Fisher ER, Paik SM, Rockette HP, et al. Prognostic significance of eosinophils and mast cells in rectal cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project (Protocol R-01). Hum Pathol 1989; 20: 159-163.
21. Lachter J, Stein M, Lichting C, Eidelman S, Munichor M. Mast cells in colorectal neoplasias and premalignant disorders. Dis Colon Rectum 1995; 38: 290-293.
22. Nielsen HJ, McArdle CS, Moesgaard F. The effect of ranitidine on long-term survival in primary colorectal cancer. GI Cancer 1998; 2: 227-233.
23. Nielsen HJ. Clinical impact of bioactive substances in blood components for transfusion. Implications for leukocyte filtration. Infuther Transfusion Med 1998; 25: 296-304.
24. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932; 35: 323-332.
25. Walls AF, Jones DB, Williams JH, Church MK, Holgate ST. Immunohistochemical identifi cation of mast cells in formaldehyde-fixed tissue using monoclonal antibodies specific for tryptase. J Pathol 1990; 162: 219-223.
26. Ladekarl M. The influence of tissue processing on quantitative histopathology in breast cancer. J Microsc 1994; 174: 93-100.
27. Gundersen HJ. Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. J Microsc 1997; 111: 219-223.
28. Andersen PK, Væth M. Simple parametric and non-parametric models for excess and relative mortality. Biometrics 1989; 45: 523-535.
29. Statistical Yearbook, National Statistics of Denmark, Copenhagen 1997 Table 58.
30. Watson SA, Wilkinson LJ, Robertson JRF, Hardcastle JD. Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine. Gut 1993; 34: 1091-1096.
31. Marks RM, Roche WR, Czerniecki M, Penny R, Nelson DS. Mast cell granules cause proliferation of human microvascular endothelial cells. Lab Invest 1986; 55: 289-294.
32. Norrby K, Woolley D. Role of mast cells in mitogenesis and angiogenesis in normal tissue and tumour tissue. Adv Biosci 1993; 89: 71-116.
33. Rouss SJ, Hartmann T, Caughey GH. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991; 88: 493-499.
34. He S, Walls AF. Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation. Eur J Pharmacol 1997; 328: 89-97.
35. Gleich GJ. Current understanding of eosinophil function. Hasp Pract 1988; 23: 137-160.
36. Ishimitsu T, Toriso M. The role of eosinophils in interleukin-2/lymphokine-activated killer cell therapy. Surgery 1993; 113: 192-199.
37. Tepper RI. The eosinophil-mediated antitumour activity of interleukin-4. J Allergy Clin Immunol 1994; 94: 1225-1231.
38. Bovo G, Brivio F, Brenna A, et al. Preoperative interleukin-2 immunotherapy induces eosinophilic infiltration in colorectal neoplastic stroma. Pathology 1995; 87: 135-138.
39. Silberstein DS, David JR. The regulation of human eosinophil function by cytokines. Immunol Today 1987; 8: 380-385.
40. Lowe D, Jorizzo J, Hutt M. Tumour-associated eosinophilia: a review. J Clin Pathol 1981; 34: 1343-1348.
41. Thompson AC, Bradley PJ, Griffin NR. Tumour-associated tissue eosinophilia and long-term prognosis for carcinoma of the larynx. Am J Surg 1994; 168: 469-471.
42. Samoszuk M. Eosinophils and human cancer. Histol Histopathol 1997; 12: 807-812.
43. Enblad G, Sundstrom C, Glimelius B. Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis. Hematol Oncol 1993; 11: 187-193.
44. Kadin M, Butmarc J, Elovic A, Wong D. Eosinophils are the major source of transforming growth factor-beta in nodular sclerosing Hodgkin's disease. Am J Pathol 1993; 142: 11-16.
45. Weller PF. The immunobiology of eosinophils. N Engl J Med 1991; 324: 1110-1118.
46. Kaufman LD. The expanding clinical spectrum of multisystem disease associated with eosinophilia. Arch Dermatol 1997; 133: 225-227.
47. Danø K, Behrendt N, Brünner N, Ellis V, Ploug M, Pyke C. The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994; 8: 189-203.
48. Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJC. Matrix metalloproteinases. Br J Surg 1997; 84: 160-166.